financetom
Business
financetom
/
Business
/
Payments firm Corpay signs $2.2 billion deal for UK's Alpha Group
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Payments firm Corpay signs $2.2 billion deal for UK's Alpha Group
Jul 23, 2025 4:18 AM

(Reuters) -Corpay said on Wednesday it would buy British financial services provider Alpha Group in a $2.2 billion (1.6 billion pounds) cash deal, as the U.S.-based business payments firm looks to expand its presence among investment managers.

Alpha provides alternative bank accounts to European-based investment managers to fund their investments and pay expenses. It holds about $3 billion of deposits in more than 7,000 client accounts.

The deal will provide Corpay a runway to expand those relationships into the U.S. and Asia, adding heft to its global reach.

Alpha shareholders will receive 4,250 pence per share, representing a 55% premium to the closing price on May 1. A day later, Corpay revealed it was in talks for a possible takeover of Alpha, which later rejected the all-cash proposal.

Shares of Alpha jumped 25% to 4,145 pence on Wednesday.

"The banking account product and Alpha's technology extend our cross-border solution set and further diversify our revenue streams," said Corpay CEO Ron Clarke.

Alpha's board intends to unanimously recommend shareholders to vote in favor of the deal. Alpha founder Morgan Tillbrook has also signed an undertaking to support the transaction.

Oppenheimer Europe and Jones Day advised Corpay on the deal, which is expected to close in the fourth quarter of 2025.

Corpay expects to fund the deal through a mix of cash, debt and non-core divestitures. The company also reiterated its second-quarter outlook.

The transaction is expected to boost its 2026 earnings per share.

($1 = 0.7387 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Nov 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Form 8.3
Form 8.3
Nov 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: First Trust Advisors L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Enviri to Sell Clean Earth Unit in $3.04 Billion Deal, Spin Off Harsco Environmental, Rail Businesses
Enviri to Sell Clean Earth Unit in $3.04 Billion Deal, Spin Off Harsco Environmental, Rail Businesses
Nov 21, 2025
09:43 AM EST, 11/21/2025 (MT Newswires) -- Enviri ( NVRI ) said Friday that it agreed to sell its hazardous-waste unit Clean Earth to French water and waste management company Veolia Environnement in a deal worth about $3.04 billion, while the American environmental company plans to spin off its Harsco environmental and rail businesses into a standalone publicly traded entity....
BioSyent Up More Than 5% As Q3 Net Income and Net Revenue Advance; New Products Generating Profitable Sales Growth
BioSyent Up More Than 5% As Q3 Net Income and Net Revenue Advance; New Products Generating Profitable Sales Growth
Nov 21, 2025
09:37 AM EST, 11/21/2025 (MT Newswires) -- BioSyent ( BIOYF ) , a profitable growth-oriented specialty pharmaceutical company, was up more than 5% early Friday after it overnight Thursday said third quarter net income and net revenue both advanced as each of its three businesses performed well over the period, while the company noted its FeraMAX and Tibella/Tibelia products continue...
Copyright 2023-2026 - www.financetom.com All Rights Reserved